Bright Uro, Inc.

Bright Uro Inc. manufactures the Glean® Urodynamics System, a wireless, catheter-free urodynamic monitoring device designed to diagnose and assess lower urinary tract conditions including overactive bladder, urinary incontinence, and neurogenic bladder. The Glean system represents a significant departure from conventional urodynamics testing by eliminating invasive catheters while maintaining diagnostic accuracy. The device features wireless connectivity, cloud-based data management, and a streamlined digital workflow suitable for deployment in any clinic or exam room setting. Clinical evidence suggests Glean enhances symptom reproduction compared to conventional urodynamic studies (UDS), where catheter-induced artifact causes up to 46% symptom non-reproduction. The system is positioned for urology practices, hospital urology departments, and specialized continence/neurogenic bladder clinics. Bright Uro targets the approximately 80 million US adults with lower urinary tract symptoms, addressing unmet needs in diagnostic accessibility, patient comfort, and clinician confidence. The company emphasizes modular design, ease of clinician training, and reduced in-office time. No specific FDA clearance status, manufacturing location, or ISO certifications are stated on the website.